Andrew C. Webb
Andrew ("Drew") Webb is Professor of Biological Sciences at Wellesley College. Born in England, he received a B.Sc. first class honours degree (majoring in Zoology) from Southampton University in 1969. He was awarded a national scholarship for continuance of his training and remained at Southampton for a further three years before receiving his Ph.D. in developmental biology. Early in 1973, Dr. Webb came to the U.S. to take up a post-doctoral research associateship at Purdue University, Indiana. He resided there until joining the Wellesley College faculty in September 1975.
At Wellesley, his teaching responsibilities have included introductory biology, genetics, and molecular, cellular and developmental biology, bioinformatics and cancer genomics, as well supervising honours research projects in molecular genetics and immunology. In addition, Professor Webb has held adjunct appointments at MIT, Tufts Medical Center and Harvard Medical School. His professional affiliations iinclude membership in the British & International Societies for Developmental Biology, the American Association of Immunologists, the American Association for the Advancement of Science, the American Association of University Professors and the Wellesley College Chapter of Sigma Xi, the Scientific research Society, ofor which he has been treasurer for over 25 years.
Dr. Webb's primary research interests are in the field of control of gene expression, specifically as it relates to the genetic response of human blood cells to signal molecules, and the use of monoclonal antibodies in targeted immunotherapy. He has published over 50 articles (including the most cited and 3 of the top 20 cited life sciences papers originating from an undergraduate institution between 1981-92) and is invited to give many lectures and talks. His research has been supported by grants from the National Institutes of Health, Research Corporation, the joint Center for Radiation Therapy, venture capital and corporate biotechnology. Dr. Webb's students have been an integral part of the molecular cloning of several human genes of clinical interest. He is co-inventor on 13 issued U.S. and international patents and serves as an expert witness in biotech patent litigation, as well a consultant to several biotechnology companies.
Profile last updated: 06/08